QUINIDEX Drug Patent Profile
Which patents cover Quinidex, and what generic alternatives are available?
Quinidex is a drug marketed by Wyeth Pharms Inc and is included in one NDA.
The generic ingredient in QUINIDEX is quinidine sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the quinidine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinidex
A generic version of QUINIDEX was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUINIDEX?
- What are the global sales for QUINIDEX?
- What is Average Wholesale Price for QUINIDEX?
Summary for QUINIDEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Patent Applications: | 4,180 |
| DailyMed Link: | QUINIDEX at DailyMed |
US Patents and Regulatory Information for QUINIDEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | QUINIDEX | quinidine sulfate | TABLET, EXTENDED RELEASE;ORAL | 012796-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
